Copyright Reports & Markets. All rights reserved.

Global Premature Ovarian Failure Cure Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Premature Ovarian Failure Cure by Type
    • 1.3.1 Overview: Global Premature Ovarian Failure Cure Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Premature Ovarian Failure Cure Consumption Value Market Share by Type in 2023
    • 1.3.3 Hormone Replacement Therapy (HRT)
    • 1.3.4 Calcium and Vitamin D Supplements
    • 1.3.5 In Vitro Fertilization (IVF)
    • 1.3.6 Stem Cell Therapy
    • 1.3.7 Others
  • 1.4 Global Premature Ovarian Failure Cure Market by Application
    • 1.4.1 Overview: Global Premature Ovarian Failure Cure Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Less than 20 Years Old
    • 1.4.3 20 to 30 Years Old
    • 1.4.4 30 to 45 Years Old
    • 1.4.5 45 Years Old and Older
  • 1.5 Global Premature Ovarian Failure Cure Market Size & Forecast
  • 1.6 Global Premature Ovarian Failure Cure Market Size and Forecast by Region
    • 1.6.1 Global Premature Ovarian Failure Cure Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Premature Ovarian Failure Cure Market Size by Region, (2019-2030)
    • 1.6.3 North America Premature Ovarian Failure Cure Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Premature Ovarian Failure Cure Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Premature Ovarian Failure Cure Market Size and Prospect (2019-2030)
    • 1.6.6 South America Premature Ovarian Failure Cure Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Premature Ovarian Failure Cure Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Premature Ovarian Failure Cure Product and Solutions
    • 2.1.4 Pfizer Premature Ovarian Failure Cure Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Pfizer Recent Developments and Future Plans
  • 2.2 Bayer
    • 2.2.1 Bayer Details
    • 2.2.2 Bayer Major Business
    • 2.2.3 Bayer Premature Ovarian Failure Cure Product and Solutions
    • 2.2.4 Bayer Premature Ovarian Failure Cure Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Bayer Recent Developments and Future Plans
  • 2.3 Novartis
    • 2.3.1 Novartis Details
    • 2.3.2 Novartis Major Business
    • 2.3.3 Novartis Premature Ovarian Failure Cure Product and Solutions
    • 2.3.4 Novartis Premature Ovarian Failure Cure Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Novartis Recent Developments and Future Plans
  • 2.4 Bioscience Institute
    • 2.4.1 Bioscience Institute Details
    • 2.4.2 Bioscience Institute Major Business
    • 2.4.3 Bioscience Institute Premature Ovarian Failure Cure Product and Solutions
    • 2.4.4 Bioscience Institute Premature Ovarian Failure Cure Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Bioscience Institute Recent Developments and Future Plans
  • 2.5 Johns Hopkins Medicine
    • 2.5.1 Johns Hopkins Medicine Details
    • 2.5.2 Johns Hopkins Medicine Major Business
    • 2.5.3 Johns Hopkins Medicine Premature Ovarian Failure Cure Product and Solutions
    • 2.5.4 Johns Hopkins Medicine Premature Ovarian Failure Cure Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Johns Hopkins Medicine Recent Developments and Future Plans
  • 2.6 Mayo Clinic
    • 2.6.1 Mayo Clinic Details
    • 2.6.2 Mayo Clinic Major Business
    • 2.6.3 Mayo Clinic Premature Ovarian Failure Cure Product and Solutions
    • 2.6.4 Mayo Clinic Premature Ovarian Failure Cure Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Mayo Clinic Recent Developments and Future Plans
  • 2.7 Baptist Health
    • 2.7.1 Baptist Health Details
    • 2.7.2 Baptist Health Major Business
    • 2.7.3 Baptist Health Premature Ovarian Failure Cure Product and Solutions
    • 2.7.4 Baptist Health Premature Ovarian Failure Cure Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Baptist Health Recent Developments and Future Plans
  • 2.8 Indira IVF
    • 2.8.1 Indira IVF Details
    • 2.8.2 Indira IVF Major Business
    • 2.8.3 Indira IVF Premature Ovarian Failure Cure Product and Solutions
    • 2.8.4 Indira IVF Premature Ovarian Failure Cure Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Indira IVF Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Premature Ovarian Failure Cure Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Premature Ovarian Failure Cure by Company Revenue
    • 3.2.2 Top 3 Premature Ovarian Failure Cure Players Market Share in 2023
    • 3.2.3 Top 6 Premature Ovarian Failure Cure Players Market Share in 2023
  • 3.3 Premature Ovarian Failure Cure Market: Overall Company Footprint Analysis
    • 3.3.1 Premature Ovarian Failure Cure Market: Region Footprint
    • 3.3.2 Premature Ovarian Failure Cure Market: Company Product Type Footprint
    • 3.3.3 Premature Ovarian Failure Cure Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Premature Ovarian Failure Cure Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Premature Ovarian Failure Cure Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Premature Ovarian Failure Cure Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Premature Ovarian Failure Cure Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Premature Ovarian Failure Cure Consumption Value by Type (2019-2030)
  • 6.2 North America Premature Ovarian Failure Cure Market Size by Application (2019-2030)
  • 6.3 North America Premature Ovarian Failure Cure Market Size by Country
    • 6.3.1 North America Premature Ovarian Failure Cure Consumption Value by Country (2019-2030)
    • 6.3.2 United States Premature Ovarian Failure Cure Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Premature Ovarian Failure Cure Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Premature Ovarian Failure Cure Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Premature Ovarian Failure Cure Consumption Value by Type (2019-2030)
  • 7.2 Europe Premature Ovarian Failure Cure Consumption Value by Application (2019-2030)
  • 7.3 Europe Premature Ovarian Failure Cure Market Size by Country
    • 7.3.1 Europe Premature Ovarian Failure Cure Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Premature Ovarian Failure Cure Market Size and Forecast (2019-2030)
    • 7.3.3 France Premature Ovarian Failure Cure Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Premature Ovarian Failure Cure Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Premature Ovarian Failure Cure Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Premature Ovarian Failure Cure Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Premature Ovarian Failure Cure Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Premature Ovarian Failure Cure Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Premature Ovarian Failure Cure Market Size by Region
    • 8.3.1 Asia-Pacific Premature Ovarian Failure Cure Consumption Value by Region (2019-2030)
    • 8.3.2 China Premature Ovarian Failure Cure Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Premature Ovarian Failure Cure Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Premature Ovarian Failure Cure Market Size and Forecast (2019-2030)
    • 8.3.5 India Premature Ovarian Failure Cure Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Premature Ovarian Failure Cure Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Premature Ovarian Failure Cure Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Premature Ovarian Failure Cure Consumption Value by Type (2019-2030)
  • 9.2 South America Premature Ovarian Failure Cure Consumption Value by Application (2019-2030)
  • 9.3 South America Premature Ovarian Failure Cure Market Size by Country
    • 9.3.1 South America Premature Ovarian Failure Cure Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Premature Ovarian Failure Cure Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Premature Ovarian Failure Cure Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Premature Ovarian Failure Cure Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Premature Ovarian Failure Cure Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Premature Ovarian Failure Cure Market Size by Country
    • 10.3.1 Middle East & Africa Premature Ovarian Failure Cure Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Premature Ovarian Failure Cure Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Premature Ovarian Failure Cure Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Premature Ovarian Failure Cure Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Premature Ovarian Failure Cure Market Drivers
  • 11.2 Premature Ovarian Failure Cure Market Restraints
  • 11.3 Premature Ovarian Failure Cure Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Premature Ovarian Failure Cure Industry Chain
  • 12.2 Premature Ovarian Failure Cure Upstream Analysis
  • 12.3 Premature Ovarian Failure Cure Midstream Analysis
  • 12.4 Premature Ovarian Failure Cure Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Premature ovarian failure (POF, also called primary ovarian insufficiency or early menopause) is a common gynecological endocrine disease characterized by the loss of ovarian function in women below 40 years. Most often, it is a non-reversible pathology leading to infertility. Normally, ovaries produce hormones and eggs until the early fifties, when they stop working and most women enter menopause. However, phenomena such as the dysfunction and the depletion of follicles (the cellular aggregates in the ovaries secreting hormones that influence the menstrual cycle) lead to POF, whose prevalence is 1/250 in women under 35 years and 1/100 in women under 40 years; the consequent loss of ovarian reserve (the number of follicles remaining in a woman’s ovaries) increases the risk of infertility, severely affecting women both physically and mentally.
    According to our (Global Info Research) latest study, the global Premature Ovarian Failure Cure market size was valued at US$ 983 million in 2023 and is forecast to a readjusted size of USD 1615 million by 2030 with a CAGR of 7.4% during review period.
    Pfizer and Bayer are the top two manufacturers of premature ovarian failure cure globally and account for over 30% of global market share in total. Geographically speaking, North America holds about 45% of global market share, followed by Asia-Pacific with over 25% share. In terms of type, hormone replacement therapy (HRT) segment holds an important share of about 50%. In terms of application, 20 to 30 years old holds over 45% of total market share.
    This report is a detailed and comprehensive analysis for global Premature Ovarian Failure Cure market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Premature Ovarian Failure Cure market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Premature Ovarian Failure Cure market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Premature Ovarian Failure Cure market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global Premature Ovarian Failure Cure market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Premature Ovarian Failure Cure
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Premature Ovarian Failure Cure market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Bayer, Novartis, Bioscience Institute, Johns Hopkins Medicine, Mayo Clinic, Baptist Health, Indira IVF, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Premature Ovarian Failure Cure market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Premature Ovarian Failure Cure market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Hormone Replacement Therapy (HRT)
    Calcium and Vitamin D Supplements
    In Vitro Fertilization (IVF)
    Stem Cell Therapy
    Others
    Market segment by Application
    Less than 20 Years Old
    20 to 30 Years Old
    30 to 45 Years Old
    45 Years Old and Older
    Market segment by players, this report covers
    Pfizer
    Bayer
    Novartis
    Bioscience Institute
    Johns Hopkins Medicine
    Mayo Clinic
    Baptist Health
    Indira IVF
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Premature Ovarian Failure Cure product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Premature Ovarian Failure Cure, with revenue, gross margin, and global market share of Premature Ovarian Failure Cure from 2019 to 2024.
    Chapter 3, the Premature Ovarian Failure Cure competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Premature Ovarian Failure Cure market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Premature Ovarian Failure Cure.
    Chapter 13, to describe Premature Ovarian Failure Cure research findings and conclusion.

    Buy now